Scan to Download
Viridian Therapeutics Inc
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Follow the latest Viridian Therapeutics Inc stock news, earnings, analyst ratings and key developments.
Viridian Therapeutics (VRDN) Q3 2026 Earnings Call: Lumvoa Revenue Reaches $24.7 Million
TradingKey Wed, Nov 4